Research programme: androgen-based therapeutics - CPEX
Latest Information Update: 14 Mar 2011
At a glance
- Originator Bentley Pharmaceuticals; Dartmouth College; Dartmouth Medical School
- Developer CPEX Pharmaceuticals; Dartmouth College; Dartmouth Medical School
- Class Testosterone congeners
- Mechanism of Action Testosterone congener stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Chronic fatigue syndrome; Fibromyalgia; Male osteoporosis
Most Recent Events
- 06 Aug 2009 No development reported - Clinical-Phase-Unknown for Fibromyalgia in USA (Topical)
- 23 Jul 2008 Bentley Pharmaceuticals has been acquired by Teva Pharmaceutical Industries
- 25 Mar 2008 Preclinical development is ongoing